Hexarelin Peptide Research
Hexarelin is a growth-hormone secretagogue from the GHRP family with a long history in endocrine research.
gh-secretagogue
Clinical
research maturity
Overview
Hexarelin is a growth-hormone secretagogue from the GHRP family with a long history in endocrine research. It is generally viewed as a potent GH stimulator with broader interest in cardiometabolic and performance-related physiology.
Related stacks
GH Optimization Stack
Apex Stack
Mechanism
Hexarelin acts through the ghrelin receptor pathway to stimulate GH secretion. Some literature also discusses cardiovascular and tissue-level effects beyond endocrine stimulation, though the GH-secretagogue function is the main anchor.
Clinical interest
Clinical interest centers on GH-axis stimulation, hormone optimization, and performance physiology. It is stronger as an endocrine research peptide than as a broadly validated therapeutic.
Research summary
The evidence includes human GH-release studies and reviews covering both secretagogue potency and possible cardiobiology. The secretagogue effect is real, but long-term therapeutic positioning remains far less developed than direct GH replacement or approved GHRH analog use.
Safety considerations
Any GH-axis secretagogue carries concerns around edema, headache, insulin sensitivity, and inappropriate IGF-1 elevation if poorly monitored. Strong endocrine activity is a reason for caution, not a reason to assume benefit.
Key information
Research stage
Clinical
Evidence rating
Moderate
Search intent
informational
Last review
Mar 13, 2026
Featured studies
(
7
)
Frequently asked questions
What is hexarelin?
Hexarelin is a ghrelin-receptor agonist peptide from the GHRP class used primarily to stimulate growth-hormone release in endocrine research.
How does hexarelin compare with ipamorelin?
Hexarelin is generally regarded as more potent but less selective, while ipamorelin is often framed as a more selective GH secretagogue with a cleaner profile in theory.